| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1085776
[patent_doc_number] => 06831060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-12-14
[patent_title] => 'Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same'
[patent_app_type] => B2
[patent_app_number] => 09/813775
[patent_app_country] => US
[patent_app_date] => 2001-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 46239
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/831/06831060.pdf
[firstpage_image] =>[orig_patent_app_number] => 09813775
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/813775 | Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same | Mar 19, 2001 | Issued |
Array
(
[id] => 6324010
[patent_doc_number] => 20020197267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Integrin binding motif containing peptides and methods of treating skeletal diseases'
[patent_app_type] => new
[patent_app_number] => 09/812485
[patent_app_country] => US
[patent_app_date] => 2001-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10331
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20020197267.pdf
[firstpage_image] =>[orig_patent_app_number] => 09812485
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/812485 | Integrin binding motif containing peptides and methods of treating skeletal diseases | Mar 18, 2001 | Issued |
| 09/744648 | AGENT FOR IMPROVING HEPACTIC FUNCTIONS IN CHRONIC HEPATITIS ND METHODS OF USING THEREOF. | Mar 15, 2001 | Abandoned |
Array
(
[id] => 1085771
[patent_doc_number] => 06831059
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-12-14
[patent_title] => 'Compositions and methods for treating gonadotrophin related illnesses'
[patent_app_type] => B2
[patent_app_number] => 09/810601
[patent_app_country] => US
[patent_app_date] => 2001-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16613
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/831/06831059.pdf
[firstpage_image] =>[orig_patent_app_number] => 09810601
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/810601 | Compositions and methods for treating gonadotrophin related illnesses | Mar 14, 2001 | Issued |
Array
(
[id] => 6792741
[patent_doc_number] => 20030088085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'MPROT12 polynucleotides and methods thereof'
[patent_app_type] => new
[patent_app_number] => 09/798723
[patent_app_country] => US
[patent_app_date] => 2001-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9482
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20030088085.pdf
[firstpage_image] =>[orig_patent_app_number] => 09798723
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/798723 | MPROT12 polynucleotides and methods thereof | Mar 1, 2001 | Abandoned |
Array
(
[id] => 5987671
[patent_doc_number] => 20020099093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'Systemic carnitine deficiency gene and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/798743
[patent_app_country] => US
[patent_app_date] => 2001-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7184
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20020099093.pdf
[firstpage_image] =>[orig_patent_app_number] => 09798743
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/798743 | Systemic carnitine deficiency gene and use thereof | Mar 1, 2001 | Issued |
Array
(
[id] => 6886817
[patent_doc_number] => 20010020086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-09-06
[patent_title] => 'Enzyme-mediated modification of fibrin for tissue engineering: incorporation of proteins'
[patent_app_type] => new
[patent_app_number] => 09/798338
[patent_app_country] => US
[patent_app_date] => 2001-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6753
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20010020086.pdf
[firstpage_image] =>[orig_patent_app_number] => 09798338
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/798338 | Enzyme-mediated modification of fibrin for tissue engineering: incorporation of proteins | Mar 1, 2001 | Issued |
| 09/786441 | Aza-cyclodepsipeptides and their use as antiparasitics | Feb 28, 2001 | Abandoned |
Array
(
[id] => 6617078
[patent_doc_number] => 20020064842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Renilla reniformis green fluorescent protein and mutants thereof'
[patent_app_type] => new
[patent_app_number] => 09/795040
[patent_app_country] => US
[patent_app_date] => 2001-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20266
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20020064842.pdf
[firstpage_image] =>[orig_patent_app_number] => 09795040
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/795040 | Renilla reniformis green fluorescent protein and mutants thereof | Feb 25, 2001 | Abandoned |
| 09/743271 | Matrix metalloproteinase inhibitors containing aminomalonic acid derivatives and peptide backbone modified derivatives thereof | Feb 22, 2001 | Abandoned |
Array
(
[id] => 6870548
[patent_doc_number] => 20030083238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Cyclic hexapeptide derivatives'
[patent_app_type] => new
[patent_app_number] => 10/030161
[patent_app_country] => US
[patent_app_date] => 2002-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42881
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20030083238.pdf
[firstpage_image] =>[orig_patent_app_number] => 10030161
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/030161 | Cyclic hexapeptide derivatives | Feb 19, 2001 | Issued |
| 09/719404 | Conjugate consisting of a lectin and a blood coagulation factor | Feb 19, 2001 | Abandoned |
Array
(
[id] => 7041240
[patent_doc_number] => 20010005724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-06-28
[patent_title] => 'Method for promoting ovulation, parturition, and lactation in mammals'
[patent_app_type] => new-utility
[patent_app_number] => 09/783114
[patent_app_country] => US
[patent_app_date] => 2001-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4444
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20010005724.pdf
[firstpage_image] =>[orig_patent_app_number] => 09783114
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/783114 | Method for promoting ovulation, parturition, and lactation in mammals | Feb 13, 2001 | Issued |
Array
(
[id] => 7644054
[patent_doc_number] => 06428984
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-06
[patent_title] => 'Method for obtaining recombinant hbsag'
[patent_app_type] => B1
[patent_app_number] => 09/701197
[patent_app_country] => US
[patent_app_date] => 2001-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4187
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/428/06428984.pdf
[firstpage_image] =>[orig_patent_app_number] => 09701197
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/701197 | Method for obtaining recombinant hbsag | Feb 7, 2001 | Issued |
Array
(
[id] => 1246245
[patent_doc_number] => 06677433
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-01-13
[patent_title] => 'Stabilization of hypoallergenic, hyperdigestible previously reduced proteins'
[patent_app_type] => B2
[patent_app_number] => 09/779375
[patent_app_country] => US
[patent_app_date] => 2001-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 34
[patent_no_of_words] => 50415
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/677/06677433.pdf
[firstpage_image] =>[orig_patent_app_number] => 09779375
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/779375 | Stabilization of hypoallergenic, hyperdigestible previously reduced proteins | Feb 6, 2001 | Issued |
Array
(
[id] => 6544453
[patent_doc_number] => 20020137671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Production and use of modified cystatins'
[patent_app_type] => new
[patent_app_number] => 09/775932
[patent_app_country] => US
[patent_app_date] => 2001-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8625
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137671.pdf
[firstpage_image] =>[orig_patent_app_number] => 09775932
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/775932 | Production and use of modified cystatins | Feb 1, 2001 | Issued |
Array
(
[id] => 6652893
[patent_doc_number] => 20030105278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Melanin-concentrating hormone analogs'
[patent_app_type] => new
[patent_app_number] => 10/182509
[patent_app_country] => US
[patent_app_date] => 2002-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8147
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20030105278.pdf
[firstpage_image] =>[orig_patent_app_number] => 10182509
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/182509 | Melanin-concentrating hormone analogs | Jan 31, 2001 | Issued |
Array
(
[id] => 7464397
[patent_doc_number] => 20040166486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'Novel translational activity-promoting higher-order structure'
[patent_app_type] => new
[patent_app_number] => 10/088750
[patent_app_country] => US
[patent_app_date] => 2002-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5547
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20040166486.pdf
[firstpage_image] =>[orig_patent_app_number] => 10088750
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/088750 | Translational activity-promoting higher-order structure | Jan 30, 2001 | Issued |
Array
(
[id] => 256386
[patent_doc_number] => 07576059
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-18
[patent_title] => 'Peptide derivatives'
[patent_app_type] => utility
[patent_app_number] => 09/772607
[patent_app_country] => US
[patent_app_date] => 2001-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4233
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/576/07576059.pdf
[firstpage_image] =>[orig_patent_app_number] => 09772607
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/772607 | Peptide derivatives | Jan 29, 2001 | Issued |
Array
(
[id] => 1017622
[patent_doc_number] => 06890514
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-10
[patent_title] => 'Methods for determining risk of developing cervical cancer'
[patent_app_type] => utility
[patent_app_number] => 10/182161
[patent_app_country] => US
[patent_app_date] => 2001-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 8534
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/890/06890514.pdf
[firstpage_image] =>[orig_patent_app_number] => 10182161
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/182161 | Methods for determining risk of developing cervical cancer | Jan 28, 2001 | Issued |